Apexigen
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Apexigen generated cash of -$30,693,000, which is less than the previous year. Cash used in financing activities reached the amount of $11,097,000 last year. Net change in cash is therefore -$8,641,000.
Cash Flow
| 2020 | -19.95M | -24.16M | 12.89M |
|---|---|---|---|
| 2021 | -23.90M | 22.02M | 37K |
| 2022 | -30.69M | 10.95M | 11.09M |
APGNW Cash Flow Statement (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Cash at beginning of period | 23.44M | 25.28M | 56.50M |
Operating activities | |||
Net income | -32.06M | -28.91M | -24.12M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 110K | 105K | 127K |
Stock-based compensation expense | 1.88M | 1.14M | 1.34M |
| Deferred income tax benefit | 1.88M | 1.14M | 1.34M |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 317K | 841K | 813K |
Cash generated by operating activities | -30.69M | -23.90M | -19.95M |
Investing activities | |||
Purchases Of Investments | -18.94M | -20.17M | -67.34M |
Investments In Property Plant And Equipment | -57K | -54K | 0 |
Acquisitions Net | 0 | 58.07M | 0 |
Cash generated by investing activities | 10.95M | 22.02M | -24.16M |
Financing activities | |||
Common Stock Issued | 20.59M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | 11.09M | 37K | 12.89M |
Net Change In Cash | -8.64M | -1.84M | -31.22M |
Cash at end of period | 14.80M | 23.44M | 25.28M |
| Data source | Data source |